Why is ams OSRAM stock sliding today?

ams OSRAM (AOS) shares fell 6.6% to CHF 15.67 after Q3 2026 results and Q4 guidance. Q4 revenue forecast (€750M-€850M) and adjusted EBITDA margin (16% ±1.5%) missed expectations. Q3 revenue (€829M) beat consensus, but adjusted EBITDA dropped 19% YoY. The stock declined on cautious outlook and margin compression.

Original reporting
Published Nov 13, 2026, 8:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AMS
Bearish
high confidence
Mentioned
$AMS
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMSBearishHigh
01

Why it matters

The guidance shortfall is the primary catalyst for the share slide, outweighing the modest Q3 revenue beat.

02

Market read

The stock's 6.6% drop reflects immediate market reaction to weaker-than‑expected Q4 outlook, making the news highly relevant for short‑term traders.

03

What to watch

The €372M gain from the Infineon divestiture masks underlying earnings weakness; analysts may focus on core profitability trends.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

ams OSRAM is a leading Austrian‑German semiconductor and lighting company listed on the SIX Swiss Exchange and also trades in the US as AMS.

Company-level read

Ticker impact

$AMSBearishHigh confidence
Context

ams OSRAM posted Q3 results and issued Q4 revenue guidance below consensus, triggering a 6.6% share decline.

Expected impact

downward pressure as investors price in weaker Q4 outlook

Evidence & confidence

Revenue guidance of €750‑€850M falls short of market expectations, and adjusted EBITDA margin guidance is also below consensus, prompting immediate downside.

Market effects

Semiconductor and lighting sector may see broader pressure as guidance miss highlights demand softness.

Swiss market likely opens lower, reflecting the stock's decline.

Limited to investors in ams OSRAM and related semiconductor exposure.

Counterpoint

If the Q3 beat on revenue and margin is viewed as a sign of resilience, the stock could rebound on short‑term overselling.

Key entities

  • ams OSRAM

    Issuer of the earnings and guidance release.

  • Infineon

    Buyer of ams OSRAM's non‑optical sensor business.

Related articles

$AMSMedAI 8/10

Ams OSRAM Swings To Q3 Profit On A Disposal Gain, Guides Q4

ams-OSRAM AG reported a Q3 net profit of €319M (€2.97/share) vs. a loss of €28M (€0.28/share) a year earlier, driven by a disposal gain. Revenue fell 3% to €829M. Adjusted EBITDA dropped to €135M. The company expects Q4 revenue of €750M-€850M and an adjusted EBITDA margin of 16.0% ±1.5%.

$AMSMed

ams-OSRAM AG (AMS) Guides Q4 Revenue to EUR 750–850M

ams-OSRAM AG reported Q3 2023 revenue of EUR 829M, up 3% sequentially but down 3% year-on-year. The company expects Q4 2023 revenue of EUR 750–850M and an adjusted EBITDA margin of 16.0% ± 1.5 percentage points. The guidance comes amid portfolio reshaping and semiconductor growth.

$AMSMed

American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results

AMERICAN SHARED HOSPITAL SERVICES (AMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results Third Quarter Revenue Increased 6% to $7.6 Million; Direct Patient Services Revenue Increased 14% Nine-Month Revenue Increased 14% to $23.1 Million; Direct Patient Services

$AMSMed

Amadeus IT Group 9-Month Revenue Rises

Amadeus IT Group reported a 3.7% revenue increase to EUR 5.075 billion for the first nine months of fiscal 2026. Net income fell slightly to EUR 1.081 billion, while adjusted profit rose to EUR 1.147 billion. CEO Luis Maroto expects 2026 outlook to be met, likely at the lower end, due to Middle East impacts.

$AMSMed

American Shared Hospital Services Q2 Net Loss Widens to $514,000 Despite Revenue Growth – Minichart

American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.